AUPH FY 2017 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$420,000+142.8% YoY

Gross Profit

$419,00099.8% margin

Operating Income

-$47M-11205.5% margin

Net Income

-$71M-16855.2% margin

EPS (Diluted)

$-0.92

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$41M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$190M

Total Liabilities

$24M

Stockholders' Equity

$166M

Cash & Equivalents

$166M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$420,000	$173,000	+142.8%
Gross Profit	$419,000	$169,000	+147.9%
Operating Income	-$47M	-$23M	-106.3%
Net Income	-$71M	-$23M	-203.9%